, China

More than 300 Chinese firms seeking billions of loans to combat nCov

Xiaomi is seeking $716m (CNY5b) to develop and sell medical equipment.

More than 300 Chinese firms are seeking bank loans amounting at least $8.2b (CNY57.4b) to cushion the effects of the coronavirus, Reuters reported.

Borrowers include food delivery giant Meituan Dianping, smartphone maker Xiaomi, ride-hailing firm Didi Chuxing Technology, facial recognition startup Megvii Technology, and cybersecurity software provider Qihoo 360.

Xiaomi is seeking $716m (CNY5b) in loans to develop and sell medical equipment such as masks and thermometers. Meituan Dianping is seeking $573m (CNY4b) for free food and deliveries to Wuhan medical staff, whilst Didi Chuxing is seeking $7.1m (CNY50m).

Beijing loan-seekers are likely to get fast-track approval and preferential interest rates.

Here's more from Reuters

Photo courtesy of Pexels.com.
 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

Asia insurers risk irrelevance as protection gaps widen
An expert said Singapore saves 36% of its income despite having high protection and critical illness gaps.
Insurance
Banks urged to turn pricing into a strategic growth lever
A consultant says data-driven pricing can boost revenue and lower funding costs without sacrificing volume.
AI governance failures threaten banks’ returns
95% of GenAI spend has no outcome as organisations remain in the early stages of adoption.